17/02/2025
Precision oncology (PO) has shifted cancer treatments away from non-specific cytotoxic treatment to a more individualised manner. Advanced diagnostic technologies, such as next-generation sequencing (NGS), optimises PO by improving the matching between patients and therapies. Nonetheless, there are still practical obstacles, such as accuracy, policy, and cost, hindering the clinical applications of PO approach. Fortunately, emerging techniques, including artificial intelligence (AI), have been implemented to enhance the clinical performance of PO. In the current Feature Story, the technical basis, clinical performance, and future development of PO approach in cancer management will be discussed.
Read More: https://www.vpulsehk.com/featured_detail.php?id=450&cid=4&page=1